GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: CD37-SMIP [8] | TRU-016 | TRU016
Compound class:
Antibody
Comment: Otlertuzumab (TRU-016) is a monospecific, humanized anti-CD37 antibody-like protein that is being investigated as a clinical therapeutic for various form of lymphoma [4,6-7]. Otlertuzumab was developed using Aptevo's modular ADAPTIRTM platform.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9832 | otlertuzumab |
Synonyms ![]() |
|
| CD37-SMIP [8] | TRU-016 | TRU016 | |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 488 |
| Other databases | |
| ChEMBL Ligand | CHEMBL3039539 |
| GtoPdb PubChem SID | 374883838 |
| Search PubMed clinical trials | otlertuzumab |
| Search PubMed titles | otlertuzumab |
| Search PubMed titles/abstracts | otlertuzumab |